Navigation Links
PRA Opens Office in Singapore
Date:2/23/2012

RALEIGH, N.C., Feb. 23, 2012 /PRNewswire/ -- PRA, a leading Clinical Research Organization, continues our expansion across the burgeoning Asia-Pacific region with the recent opening of an office in Singapore. The office will serve as PRA's central clinical operations location for the region, strengthening the quality and timeliness of our deliverables to sponsors.

The Singapore facility, conveniently located in the heart of the city-state, will provide monitoring, project management, safety reporting, feasibility and other services.

"Building our capability across the region with the center in Singapore permits our sponsors to experience a wider range of services and expertise," said Helen Neal, PRA's Director of Clinical Operations for Asia-Pacific. "This location provides our teams with access to experts and resources within their time zone, positively impacting our speed and quality of delivery on projects."

Geographically renowned as the region's pharmaceutical and biomedical center, Singapore is the ideal location from which to deliver centralized study support to the region. This city-state serves as an excellent logistics hub with high fluency rates in English, and its government strongly promotes and encourages CROs to conduct cutting-edge clinical research.

"Opening a Singapore office for PRA is an exciting and significant milestone in the company's evolution and is evidence that PRA acknowledges and embraces the full potential that the Asia-Pacific region can bring to the global business going forward," said Ms. Neal.

PRA has been strategically expanding our Asia-Pacific operations since 2000. In addition to Singapore, PRA operates in eight other countries within the region: Korea, Taiwan, China, Hong Kong, Thailand, Australia, New Zealand, and India.

About PRA   

PRA is transforming clinical trials through our people, innovation and transparency. PRA provides personaliz
'/>"/>

SOURCE PRA
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Stevenage Bioscience Catalyst Opens With Exciting Year Ahead
2. Alchem International Opens Sales and Marketing Office in the U.S.
3. CoreLab Partners Opens Office in Tokyo, Japan
4. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
5. Golden Seeds Opens Office in PLSG Incubator
6. MIABE standard opens up new opportunities in drug discovery
7. Medical Malpractice Insurance Company- Healthcare Providers Insurance Exchange (HPIX) has Expanded its Presence in New Jersey, Opens New Office
8. "Pure" Human Blood Stem-Cell Discovery Opens Door to Expanding Cells for More Clinical Use
9. New England Biolabs Opens New Subsidiary Office in France
10. New beamline at MAX II opens for research
11. Discovery opens the door to electricity from microbes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... (PRWEB) November 28, 2014 The report ... for all the important sub-segments of the market, in ... It maps the growth rates and market sizes for ... poised to witness rapid growth. It also includes analysis ... These company profiles include the financial performances, product portfolios, ...
(Date:11/27/2014)... 2014 First articles published ... Elsevier , a world-leading provider of scientific, ... to announce the launch of a new journal: ... The launch of Extreme Mechanics Letters ... forefront of applied sciences such as micro and nanotechnologies, ...
(Date:11/26/2014)... The report on the Global Smart Sensor Market in ... revenue forecasts and market trends. It expects the market ... to 2018. At the projected rate, the market is ... 2018. , Browse through the Global Smart Sensor Market ... market segmentation and in-depth analysis supported by a list ...
(Date:11/26/2014)... 2014 The announced sales of three healthcare ... looking to expand in non-healthcare areas, says Kalorama Information. ... research firm says that  Siemens is the third largest ... of the IVD market , with 5.5 billion in ... composition would likely affect IVD market shares.  ...
Breaking Biology Technology:Glycomics Market by Application, Product & End-Users is estimated to reach $928.11 Million by 2019 - New Research Report by MarketsandMarkets 2Glycomics Market by Application, Product & End-Users is estimated to reach $928.11 Million by 2019 - New Research Report by MarketsandMarkets 3Glycomics Market by Application, Product & End-Users is estimated to reach $928.11 Million by 2019 - New Research Report by MarketsandMarkets 4Glycomics Market by Application, Product & End-Users is estimated to reach $928.11 Million by 2019 - New Research Report by MarketsandMarkets 5Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 2Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 3Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 2Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 3Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 4Kalorama: Sale of Three Siemens Healthcare Units Raises Questions About Firm's IVD Future 2
... Inc. today announced that data from its phase 1/2 ... be highlighted in an oral presentation at the 50th ... in San Francisco, California, on December 9, 2008. , ... of the XIAP Antisense Oligonucleotide (AEG35156) in Combination with ...
... BioMarin Pharmaceutical,Inc. (Nasdaq: BMRN ) today announced that ... update at the Piper,Jaffray Healthcare Conference in New York City ... Interested parties may access a ... of the BioMarin website, http://www.BMRN.com . A,replay of the ...
... JOLLA, Calif., Nov. 25 TorreyPines Therapeutics, Inc.,(Nasdaq: ... from Eli Lilly & Company,a reduction in certain royalty ... sales of TorreyPines, clinical-stage compounds NGX426 and tezampanel,should either ... rate will be reduced three percentage points and the ...
Cached Biology Technology:Aegera Therapeutics' phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting 2Aegera Therapeutics' phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting 3BioMarin to Present at the Piper Jaffray Healthcare Conference 2TorreyPines Therapeutics Enters into Agreement to Reduce Royalty Rates and Delay Clinical Milestone Payments Due to Eli Lilly for NGX426 and Tezampanel 2
(Date:11/21/2014)... 20, 2014 C-Labs LLC, a leading provider ... Things (IoT), today announced the appointment of John ... Previously a strategic advisor to the firm, Mr. Traynor ... Traynor is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... 18, 2014   EyeLock Inc. , a ... MorphoTrust USA (Safran), a leading U.S. ... a strategic partnership to offer comprehensive biometric identity ... (MVA), airport screening and financial services markets. ... serves consumers through a nationwide network of 1,100 ...
(Date:11/7/2014)... Researchers led by Dr. Debra Auguste, associate professor, ... at The City College of New York, have ... treatment for one of the most aggressive forms ... (TNBCs) have a high mortality rate owing to ... effective therapeutic options. However, Professor Auguste,s team, discovered ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... Researchers have long known that humans lack a key enzyme ... even plants -- that reverses severe sun damage. For ... at the atomic level to repair sun-damaged DNA. The ... prevention. In the early online edition of the journal ...
... Eeva Karjalainen, of the Finnish Forest Research Institute, Metla, "feel ... not many of us know that there is also scientific ... and other natural, green settings can reduce stress, ... Forest visits may also strengthen our immune system by increasing ...
... (SACRAMENTO, Calif.) A shared decision-making process would assist ... challenging and controversial choices presented when infants are born ... are being considered for elective corrective surgery, a new ... instances in which infants are born with conditions that ...
Cached Biology News:Researchers discover how key enzyme repairs sun-damaged DNA 2Study recommends that parents, physicians share decisions in sex development disorder surgery 2Study recommends that parents, physicians share decisions in sex development disorder surgery 3Study recommends that parents, physicians share decisions in sex development disorder surgery 4
Edited by D. Rickwood, T.C. Ford and J.T. Steensgaard (1994) Compiles core data required by researchers carrying out any centrifugal separation, whether working with cells, organelles or macromolec...
Rat neural stem cell kits are intended for the in vitro growth and commitment to neuronal and glial lineage differentiation, of cultured fetal rat neural stem and progenitor cells expanded using FGF-...
Antibodies were affinity purified using epitopes specific to JLP immobilized on solid support....
... Price (1996) • This issue ... chemistry and the purification and ... on the following procedures is ... amino acid analysis and the ...
Biology Products: